Drug-resistant gonorrhoea on the rise in Europe, ECDC warns
The European Centre for Disease Prevention and Control (ECDC) has warned of an increase in ceftriaxone-resistant gonorrhoea across Europe. The rise in these resistant strains poses a significant challenge for the treatment of the sexually transmitted infection.
Why it matters
Antibiotic resistance in common infections is a major public health concern that threatens the efficacy of standard medical treatments.
An increasing number of European countries have detected gonococcal strains resistant to the antibiotic ceftriaxone, the first-line drug to treat gonorrhoea infection. Alongside growing evidence of the domestic spread of such resistant strains in Europe over the last two years, this poses a significant challenge for future treatment options for one of the most common sexually transmitted diseases worldwide, according to an assessment issued by the European Centre for Disease Prevention and Control (ECDC).
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in